Exploring novel biomarkers and immunotherapeutic targets for biofeedback therapies to reveal the tumor-associated immune microenvironment through a multimetric analysis of kidney renal clear cell carcinoma
This study presents an innovative prognostic framework for KIRC based on multi-omics approaches, seamlessly incorporating CRs. This model holds promise for improving the accuracy of prognosis prediction for KIRC patients, laying a robust foundation for the development of targeted immunotherapies.
Authors
- Gang Tian (ORCID: https://orcid.org/0000-0002-4116-3215)
- Guobing Wang (ORCID: https://orcid.org/0000-0001-8362-9186)
- Cheng‐Lu Jiang (ORCID: https://orcid.org/0000-0002-2130-7760)
- Wenqi Feng (ORCID: https://orcid.org/0009-0002-8845-8667)
- Lai Jiang (ORCID: https://orcid.org/0000-0001-7778-2336)
- Haiqing Chen (ORCID: https://orcid.org/0009-0009-4555-9362)
- Jinbang Huang
Institutions
- Affiliated Hospital of Southwest Medical University (CN)
- Second People’s Hospital of Yibin (CN)
Publication Details
- Journal
- Discover Oncology
- Published
- 2025-03-13
- DOI
- https://doi.org/10.1007/s12672-025-02090-5
- Primary Topic
- Cancer Immunotherapy and Biomarkers
- Type
- article
- Field-Weighted Citation Impact
- 0.00